The 22/11 risk prediction model: A validated model for predicting 30-day mortality in patients with cirrhosis and spontaneous bacterial peritonitis

American Journal of Gastroenterology

Volumn 108, Issue 9, 2013, Pages 1473-1479

  Tandon, Puneeta ^a   Kumar, Deepali ^a   Seo, Yeon Seok ^b   Chang, Hsiu Ju ^a   Chaulk, Jennifer ^a   Carbonneau, Michelle ^a   Qamar, Hina ^a   Keough, Adam ^a   Mansoor, Nadia ^a   Ma, Mang ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CEPHALOSPORIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PERITONITIS; FEMALE; HUMAN; LEUKOCYTE COUNT; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; PRACTICE GUIDELINE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK ASSESSMENT; TERTIARY HEALTH CARE; VALIDATION STUDY;

AGED; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MODELS, THEORETICAL; PERITONITIS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK; RISK ASSESSMENT;

EID: 84883744264     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2013.204     Document Type: Article

References (31)

1. Tandon P , Garcia-Tsao G. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis 2008 ; 28 : 26-42.
2. Fernandez J , Acevedo J , Castro M et al. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology 2012 ; 55 : 1551-61.
3. Wiest R , Krag A , Gerbes A. Spontaneous bacterial peritonitis: recent guidelines and beyond. Gut 2012 ; 61 : 297-310.
4. Runyon BA. Management of adult patients with ascites due to cirrhosis: an update. Hepatology 2009 ; 49 : 2087-107.
5. European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010 ; 53 : 397-417.
6. Tandon P , Garcia-Tsao G. Renal dysfunction is the most important independent predictor of mortality in cirrhotic patients with spontaneous bacterial peritonitis. Clin Gastroenterol Hepatol 2011 ; 9 : 260-5.
7. Sort P , Navasa M , Arroyo V et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999 ; 341 : 403-9.
8. Heo J , Seo YS , Yim HJ et al. Clinical features and prognosis of spontaneous bacterial peritonitis in Korean patients with liver cirrhosis: a multicenter retrospective study. Gut Liver 2009 ; 3 : 197-204.
9. Al Sibae MR , Cappell MS. Accuracy of MELD scores in predicting mortality in decompensated cirrhosis from variceal bleeding, hepatorenal syndrome, alcoholic hepatitis, or acute liver failure as well as mortality after non-transplant surgery or TIPS. Dig Dis Sci 2011 ; 56 : 977-87.
10. Kamath PS , Wiesner RH , Malinchoc M et al. A model to predict survival in patients wiThend-stage liver disease. Hepatology 2001 ; 33 : 464-70.
11. Said A , Williams J , Holden J et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004 ; 40 : 897-903.
12. Bernardi M , Gitto S , Biselli M. The MELD score in patients awaiting liver transplant: strengths and weaknesses. J Hepatol 2011 ; 54 : 1297-306.
13. Ariza X , Castellote J , Lora-Tamayo J et al. Risk factors for resistance to ceft riaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis. J Hepatol 2012 ; 56 : 825-32.
14. Cho JH , Park KH , Kim SH et al. Bacteremia is a prognostic factor for poor outcome in spontaneous bacterial peritonitis. Scand J Infect Dis 2007 ; 39 : 697-702.
15. Bert F , Andreu M , Durand F et al. Nosocomial and community-acquired spontaneous bacterial peritonitis: comparative microbiology and therapeutic implications. Eur J Clin Microbiol Infect Dis 2003 ; 22 : 10-5.
16. Nobre SR , Cabral JE , Gomes JJ et al. In-hospital mortality in spontaneous bacterial peritonitis: a new predictive model. Eur J Gastroenterol Hepatol 2008 ; 20 : 1176-81.
17. Musskopf MI , Fonseca FP , Gass J et al. Prognostic factors associated with in-hospital mortality in patients with spontaneous bacterial peritonitis. Ann Hepatol 2012 ; 11 : 915-20.
18. Poca M , Concepcion M , Casas M et al. Role of albumin treatment in patients with spontaneous bacterial peritonitis. Clin Gastroenterol Hepatol 2012 ; 10 : 309-15.
19. Bone RC , Balk RA , Cerra FB et al. Defi nitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992 ; 101 : 1644-55.
20. Amitrano L , Guardascione MA , Manguso F et al. The Effectiveness of current acute variceal bleed treatments in unselected cirrhotic patients: refi ning short-term prognosis and risk factors. Am J Gastroenterol 2012 ; 107 : 1872-8.
21. Bauer MP , Hensgens MP , Miller MA et al. Renal failure and leukocytosis are predictors of a complicated course of Clostridium diffi cile infection if measured on day of diagnosis. Clin Infect Dis 2012 ; 55 (Suppl 2) : S149-53.
22. Crabtree TD , Pelletier SJ , Antevil JL et al. Cohort study of fever and leukocytosis as diagnostic and prognostic indicators in infected surgical patients. World J Surg 2001 ; 25 : 739-44.
23. Kumar A , Ellis P , Arabi Y et al. Initiation of inappropriate antimicrobial therapy results in a fi vefold reduction of survival in human septic shock. Chest 2009 ; 136 : 1237-48.
24. Cheong HS , Kang CI , Lee JA et al. Clinical signifi cance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis. Clin Infect Dis 2009 ; 48 : 1230-6.
25. Tabah A , Koulenti D , Laupland K et al. Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study. Intensive Care Med 2012 ; 38 : 1930-45.
26. Morata L , Cobos-Trigueros N , Martinez JA et al. Infl uence of multidrug resistance and appropriate empirical therapy on the 30-day mortality rate of Pseudomonas aeruginosa bacteremia. Antimicrob Agents Chemother 2012 ; 56 : 4833-7.
27. Tandon P , Delisle A , Topal JE et al. High prevalence of antibiotic-resistant bacterial infections among patients with cirrhosis at a US liver center. Clin Gastroenterol Hepatol 2012 ; 10 : 1291-8.
28. Chen TA , Tsao YC , Chen A et al. Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis. Scand J Gastroenterol 2009 ; 44 : 619-25.
29. de Araujo A , de Barros Lopes A , Rossi G et al. Low-dose albumin in the treatment of spontaneous bacterial peritonitis: should we change the standard treatment? Gut 2012 ; 61 : 1371-2.
30. Belcher JM , Garcia-Tsao G , Sanyal AJ et al. Association of AKI with mortality and complications in hospitalized patients with cirrhosis. Hepatology 2013 ; 57 : 753-62.
31. Garcia-Tsao G , Parikh CR , Viola A. Acute kidney injury in cirrhosis. Hepatology 2008 ; 48 : 2064-77.